As per IMS, Fluoxetine tablets have a market size of USD 23.9 million. This approval further strengthens the company’s presence in the Fluoxetine portfolio, complementing the existing approval of Fluoxetine capsules, which has a market size of USD106 million, the Bengaluru based firm said.
